🧬💡 The End of Depression Treatment Guesswork: MindLight™ is Changing Lives
Would you like to be featured in our newsletter🔥 and get noticed, QUICKLY 🚀 (159+ subscribers)? Reply to this email or send an email to editor@digitalhealthbuzz.com, and we can take it from there.
⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐
Would you like to be featured in our newsletter🔥 and get noticed, QUICKLY 🚀 (159,000+ subscribers)? Simply reply to this email or send an email to editor@digitalhealthbuzz.com, and we can take it from there.
⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐⭐
What if a simple blood test could tell you whether an antidepressant will work—before you spend months or even years trying different medications?
That’s exactly what MindLight™ is making possible.
Here’s the problem: Right now, prescribing antidepressants is essentially educated guesswork. Only 41% of patients respond positively to SSRIs, leaving millions struggling through ineffective treatments while their depression continues. It’s a painful, frustrating process that can take years to resolve.
The breakthrough: Circular Genomics has developed MindLight™, an innovative antidepressant response test that uses cutting-edge circular RNA (circRNA) biomarkers to predict whether a patient will respond to SSRIs—with 76% accuracy.
Here’s what makes this game-changing:
3x better outcomes — Patients categorized as “High Likelihood of Response” are over three times more likely to benefit from SSRIs
Fast results — Just 3-5 business days from blood draw to actionable insights
Simple process — Only requires a small 5 mL blood sample
Precision medicine — Finally, personalized depression treatment based on your unique biology, not trial and error
Read the full story here to discover how this biomarker-based approach is transforming mental health care—and why it could save patients from the devastating cycle of ineffective treatments.
This isn’t just another pharmacogenomic test. It’s a paradigm shift in psychiatry that’s already backed by clinical evidence from the EMBARC study, one of the largest antidepressant response studies ever conducted.
The future of depression treatment is here—and it starts with knowing what will work for you. Dive into the science and clinical evidence behind MindLight™ in our latest feature.
🔥 Digital Health Buzz! community
We noticed that there are many exciting Health startups that consumers are really keen to work with. Unfortunately, many of these startups close their doors before even getting noticed (aka vanish)!
To tighten this gap, we started the Digital Health Buzz! community to bring Health startup founders and consumers together under one roof!
Go ahead and join the group to hunt some interesting Health startups, land some potential leads, conduct fruitful discussions, get our questions answered, and more…
Joining the group is FREE for a limited time only!
